ArticleAmerican journal of surgery2025
Medicaid expansion and thyroid cancer stage at presentation: A comparative study of two US states.
Article in American journal of surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Medicaid Expansion and Overall Mortality Among Women With Breast Cancer.JAMA network open · 2026Article
- Medicaid expansion and inpatient hospital charges among women with major depressive disorders.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe Affordable Care Act (ACA) enabled states to expand Medicaid eligibility, extending coverage to millions, particularly in California. While Medicaid expansion has been linked to earlier diagnoses in several cancers, its impact on thyroid cancer-a slow-growing malignancy lacking formal screening-remains unclear.
objectiveTo assess whether Medicaid expansion influenced thyroid cancer stage at presentation.
methodsA retrospective cohort study using SEER data (2009-2020) compared adults aged 18-64 diagnosed with thyroid cancer in California (expansion) and Texas (non-expansion). Difference-in-differences logistic regression evaluated stage changes pre- (2009-2013) and post- (2016-2020) expansion, excluding a 2014-2015 washout period.
resultsAmong 63,073 patients, no significant difference in stage at diagnosis was observed between states. Estimates for localized, regional, and distant disease changes ranged from -1.3 % to 1.1 % (all 95 % CIs included zero).
conclusionMedicaid expansion was not associated with a significant shift in thyroid cancer stage at presentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.